1. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation
   Yueh-Shan Weng et al, 2015, Am. J. Chin. Med. CrossRef
2. The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review.
   Xiuping Chen et al, 2014, Med Res Rev CrossRef
3. Phytoestrogen, tanshinone IIA diminishes collagen deposition and stimulates new elastogenesis in cultures of human cardiac fibroblasts
   Shuai Mao et al, 2014, Experimental Cell Research CrossRef
4. Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro
   Ting Chu et al, 2012, International Journal of Pharmaceutics CrossRef
5. null
   María Gómez-Serranillos Cuadrado et al, 2012 CrossRef
6. Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction
   Sheng-Teng Huang et al, 2017, Sci. Rep. CrossRef
7. Multiple pro-apoptotic targets of abietane diterpenoids from Salvia species
   M. Akaberi et al, 2015, Fitoterapia CrossRef
8. The Molecular Mechanisms of Tanshinone IIA on the Apoptosis and Arrest of Human Esophageal Carcinoma Cells
   Jiang-Feng Wang et al, 2014, BioMed Research International CrossRef
9. Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents
   Yizhou Dong et al, 2011, Nat. Prod. Rep. CrossRef
10. Tanshinones: sources, pharmacokinetics and anti-cancer activities.
    Yong Zhang et al, 2012, Int J Mol Sci CrossRef
11. Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line
    Rong Zhang et al, 2011, Toxicology and Applied Pharmacology CrossRef
12. Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats
    Shenshen Yang et al, 2012, Journal of Pharmaceutical and Biomedical Analysis CrossRef
13. Natural products targeting telomere maintenance
    Jack Li-Yang Chen et al, 2011, Med. Chem. Commun. CrossRef
14. Metabolic engineering and biotechnological approaches for production of bioactive diterpene tanshinones in Salvia miltiorrhiza
    Guoyin Kai et al, 2014, Biotechnology Advances CrossRef
15. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65
    CHIN-CHENG SU et al, 2012 CrossRef
16. Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway
    JIAN ZHANG et al, 2014 CrossRef
17. Tanshinone IIA Inhibits VEGF Secretion and HIF-1α Expression in Cultured Human Retinal Pigment Epithelial Cells under Hypoxia
    Rami M. Alzhrani et al, 2017, Current Eye Research CrossRef
18. Cancer Prevention and Therapy
    Seong Woo Yoon et al, 2014, Integr Cancer Ther CrossRef
19. Tanshinone IIA arrests cell cycle and induces apoptosis in 786-O human renal cell carcinoma cells
    XIANLI WEI et al, 2012 CrossRef
20. Tanshinone IIA ameliorates lipopolysaccharide-induced inflammatory response in bronchial epithelium cell line BEAS-2B by down-regulating miR-27a
    Xiuxia Liu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
21. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA
    Zhenyu Xu et al, 2018, Phytomedicine CrossRef
22. Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo
    Qiong Wu et al, 2018, J. Med. Chem. CrossRef
23. In silico drug repositioning based on drug-miRNA associations
    Xu Zhou et al, 2019 CrossRef
24. null
    John H. K. Yeung, 2013 CrossRef
25. Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT
    SiMin He et al, 2019, Contrast Media & Molecular Imaging CrossRef
26. null
    Esthelle Hoedt et al, 2019 CrossRef
27. Regioselective Glucuronidation of Tanshinone IIa after Quinone Reduction: Identification of Human UDP-Glucuronosyltransferases, Species Differences, and Interaction Potential
    Qiong Wang et al, 2010, Drug Metab Dispos CrossRef
28. null
    , 2019 CrossRef
29. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models
    Zhen-Biao Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
30. Tanshinone IIA improves diabetes mellitus via the NF-κB-induced AMPK signal pathway.
    Feng-Yi Yuan et al, 2018, Exp Ther Med CrossRef
31. Tanshinone IIA induces apoptosis of ovarian cancer cells in�vitro and in�vivo through attenuation of PI3K/AKT/JNK signaling pathways
    Xian Zhang et al, 2018, Oncol Lett CrossRef
32. Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis.
    Mingqian Hao et al, 2020, PeerJ CrossRef
33. In silico analysis based on constituents of the medicinal plant Xuebijing (XBJ) to identify candidate treatment agents for sepsis in the omics-driven research era
    Zhenyu XU et al, 2021, Minerva Biotecnol CrossRef
34. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Front. Pharmacol. CrossRef
35. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
    Zhou Jin et al, 2022, Front. Pharmacol. CrossRef
36. Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms
    Huan Zhao et al, 2022, Front. Pharmacol. CrossRef
37. Tanshinone IIA: Pharmacology, Total Synthesis, and Progress in Structure-modifications
    Xing Huang et al, 2022, CMC CrossRef
38. Neuroprotective Effects of Tanshinone IIA in Experimental Model of Parkinson Disease in Rats
    Li Zhang et al, 2022, Arabian Journal of Chemistry CrossRef
39. Molecular mechanisms of Tanshinone IIA in Hepatocellular carcinoma therapy via WGCNA-based network pharmacology analysis
    HAN ZHAO et al, 2022 CrossRef